◆ 会议时间：2025年6月2-7日
◆ 会议地点：阿根廷 布宜诺斯艾利斯

◆ 会议简介：

2025年第63届粒子治疗协作组(PTCOG)年会将于2025年6月2-7日在阿根廷布宜诺斯艾利斯举行，PTCOG年会是粒子治疗领域首屈一指的聚焦前沿科学、技术 和临床应用的科学会议，预计将有超过1000名来自世界各地的专业人士与会，与会者包括医生、物理学家、生物学家、基础科学家、护士、放射治疗师，剂量师，管理人员和行业专业人士等等。

国际粒子治疗协作委员会(PTCOG)成立于1985年，是一个由对质子、轻离子和重带电粒子放射治疗感兴超的科学家和专业人士组成的非营利性国际组织。PTCOG的使命是促进粒子治疗的科学、技术和实际临床应用，最终目标宣是最终目标是在放射疗法中尽可能提高癌症治疗水平。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）。

PTCOT 63- 63rd Annual Conference of the Particle Therapy Co-Operative Group

Dates:
2-7 June 2025

Venue:
Argentine Proton Therapy Center (CeArP)
Buenos Aires, Argentina

以下为上届会议信息

摘要征文投稿：

Abstract Submission Deadline is rapidly approaching on 23 January 2024, 23:59 CET

Abstract Notifications: 11 March 2024

RULES FOR SUBMISSION

Please read the submission rules before submitting an abstract.

• Abstracts must be submitted online via the website only.
  ABSTRACTS SUBMITTED BY EMAIL WILL NOT BE ACCEPTED.
• Presentation Type: Abstracts may be submitted for oral or e-poster presentation.
  The Scientific Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.
• Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
• Limitations:
• An individual may be listed as the presenting author on one abstract only.
• Presenting authors must be registered participants. Only abstracts of authors who have paid their registration fees by 28 March 2024 will be scheduled for presentation and included for publication.
• Submission of an abstract acknowledges your acceptance for the abstract to be published in the official Conference publications.
• The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.
• Previously Presented/Published Policy:
  • Abstracts must be original and must not be or have been published or presented at any other meeting prior to the Conference. Abstracts containing updated information or modified data to previously published or presented abstracts will not be considered or accepted for presentation.
• Abstracts must be submitted in English.
• Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.

​GUIDELINES FOR SUBMISSION

​Before you begin, please prepare the following information:

• ​Presenting author’s contact details:
  -Full first and family name(s)
  – Email address
  – Affiliation details: department, institution / hospital, city, state (if relevant), country
  – Phone number
• Author and co-authors’ details
• Preferred Presentation type: Oral or E-Poster ​
• Abstract title – must be in sentence case and limited to 20 words. Please submit symbols as words.
• Abstract text – limited to 350 words including acknowledgements. Please note: word count is affected when tables are included.
• Abstract topic– select the abstract topic per the list of topics.
• Images– The maximum file size of each image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. You may upload images in JPG, GIF or PNG format. You may upload up to 2 images / tables
• Abstracts should clearly state:
  Background and aims
  Methods
  Results
  Conclusions  
• Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
• Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
• Submissions may not contain patient names, hospital ID numbers or other identifying information.
• The submission form allows you to store your abstract as a DRAFT until the deadline. After the deadline if not submitted, drafts will be deleted.
• Click on the SUBMIT button at the end of the process in order to submit your abstract. Changes will not be possible to your abstract after it is submitted.
• You will receive an abstract ID number via email after you have submitted your abstract. Please refer to this abstract number in all correspondence regarding the abstract.
• Please contact us if you have not received confirmation that your abstract has been submitted.
• Please do not submit multiple copies of the same abstract.

Dear Colleagues,

On behalf of the PTCOG Executive Committee and of the Local Organizing Committee, we are pleased to invite you to Singapore for the 62nd Annual Conference of the Particle Therapy Cooperative Group. Singapore was recently named the most beautiful city in Asia and will surprise you with its fantastic food and amazing landscape. With 3 proton therapy centers and 6 gantries in a population of only 5.4 million, Singapore is the country with the highest number of proton therapy rooms per inhabitant worldwide. A perfect location for our PTCOG 62!

This year’s conference will start with two-day educational sessions followed by 3-days of multi-session scientific reports with several subcommittee meetings in between.  The conference theme is “Synergy through collaboration“, stressing the importance of collaboration in the field of particle therapy. We expect an outstanding scientific program covering clinics, physics, and biology topics, many plenary talks and round tables for debating hot issues in particle therapy.

Owing to the exceptional growth of proton therapy centers worldwide, PTCOG reached over 4,000 members and nearly 100 facility representatives in the Steering Committee. PTCOG 61 in Madrid reached a record number of 1,600 participants on site, demonstrating the growing interest and research in particle therapy. PTCOG now has 16 active Sub-Committees that will report their activities in a dedicated session during the scientific meeting. You are welcome to join these Sub-Committees at any time. This will be the first year where the new Scholar-in-Training (SIT) Sub-Committee will be involved in the educational and scientific program planning, resulting in a higher involvement of the younger generations in the PTCOG leadership and in the meeting. We will also discuss PTCOG funding for small research projects and the future of the PTCOG Scientific journal, the International Journal of Particle Therapy, which just got the first impact factor.  The Steering Committee will be called to elect new members of the Executive Committee and to decide the site of the 2027 PTCOG annual conference.

We look forward to your participation and spending time with you in Singapore. We are sure that this will be an awesome scientific experience and we also hope you will enjoy the local flavor and hospitality.

Welcome to PTCOG 62!

Marco Durante
PTCOG President  

Michael Wang Lian Chek
Local Organising Committee (LOC)

Martin Jermann
PTCOG Secretary

Youngyih Han
PTCOG-AO Chair

注册费：

Registration fees (in USD):

Fees apply to payments received prior to the indicated deadlines.

*The discounted registration fees applicable to Radiation Therapists, Dosimetrists and Students are only available to those providing valid credentials requested via the registration form. The standard registration fee will apply to anyone unable to prove one of these three positions when requested.

Registration Fees Include:

Educational Sessions Categories (10-11 June):

• All Educational Sessions included in the final program.
• Complimentary access to the Educational Sessions Welcome Reception
• Complimentary access to the Exhibition Opening and Scientific Meeting Welcome Reception
• Refreshments during coffee breaks as indicated in the program.
• Conference materials provided via registration.

Scientific Meeting Categories (12-14 June):

• All Scientific Meeting Sessions as included in the final program.
• Complimentary access to the Exhibition Opening and Scientific Meeting Welcome Reception (on the 11 of June, afternoon).
• Access to PTCOG 62 Exhibition and poster area
• Refreshments during coffee breaks as indicated in the program.
• Conference materials provided via registration.

All Session Categories Include (10-14 June):

• All content as per final program
• Complimentary access to the Educational Sessions Welcome Reception
• Complimentary access to the Exhibition Opening and Scientific Meeting Welcome Reception
• Access to PTCOG 62 Exhibition and poster area
• Refreshments during coffee breaks as indicated in the program.
• Conference materials provided via registration

◆ 参会对象：医生、物理学家、生物学家、基础科学家、护士、放射治疗师，剂量师，管理人员以及从事该领域研究的科学家、研究人员、企业代表等等。